NAFLD and NASH are often associated with insulin resistance, glucotoxicity and accompanied by an increase in cholesterol, triglycerides, insulin, as well as decrease in adiponectin [12]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.